Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: A study on methacarn-fixed tissue

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 4042-4050

  Daniele, Lorenzo ^a   Annaratone, Laura ^a   Allia, Elena ^a   Mariani, Sara ^a   Armando, Enrico ^a   Bosco, Martino ^a   Macrì, Luigia ^a   Cassoni, Paola ^a   D'Armento, Giuseppe ^a   Bussolati, Gianni ^a   Cserni, Gabor ^b   Sapino, Anna ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Breast neoplasm; Methacarn fixation; RT PCR; Sentinel lymph node

Indexed keywords

ACETIC ACID; CHLOROFORM; METHACARN; METHANOL; PRIMER DNA;

AGED; ARTICLE; BREAST TUMOR; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; ONCOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

ACETIC ACID; AGED; BREAST NEOPLASMS; CHLOROFORM; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEDICAL ONCOLOGY; METHANOL; MIDDLE AGED; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

EID: 77449120592     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00449.x     Document Type: Article

References (35)

1. Lyman GH, Giuliano AE, Somerfield MR. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005, 23:7703-20.
2. Ferrari A, Rovera F, Dionigi P. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Expert Rev Anticancer Ther. 2006, 6:1503-15.
3. Cserni G, Amendoeira I, Apostolikas N. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2004, 57:695-701.
4. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006, 56:37-47.
5. Langer I, Marti WR, Guller U. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg. 2005, 241:152-8.
6. Langer I, Guller U, Viehl CT. Axillary lymph node dissection for sentinel lymph node micrometastases can be safely omitted in early breast cancer patients: long-term outcomes of a prospective observational study. Ann Surg Oncol. 2008, 15:9.
7. Schoenfeld A, Luqmani Y, Smith D. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994, 54:2986-90.
8. Min CJ, Tafra L, Verbanac KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res. 1998, 58:4581-4.
9. Marchetti A, Buttitta F, Bertacca G. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol. 2001, 195:186-90.
10. Bostick PJ, Huynh KT, Sarantou T. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer. 1998, 79:645-51.
11. Mitas M, Mikhitarian K, Walters C. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001, 93:162-71.
12. Nissan A, Jager D, Roystacher M. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer. 2006, 94:681-5.
13. Abdul-Rasool S, Kidson SH, Panieri E. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol. 2006, 59:289-97.
14. Manzotti M, Dell'Orto P, Maisonneuve P. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer. 2001, 95:307-12.
15. Dell'Orto P, Biasi MO, Del Curto B. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat. 2006, 98:185-90.
16. Langer I, Guller U, Berclaz G. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat. 2008, 113:129-36.
17. Sapino A, Cassoni P, Zanon E. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer. 2003, 88:702-6.
18. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002, 161:1961-71.
19. Stanta G, Mucelli SP, Petrera F. A novel fixative improves opportunities of nucleic acids and proteomic analysis in human archive's tissues. Diagn Mol Pathol. 2006, 15:115-23.
20. Delfour C, Roger P, Bret C. RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells. J Mol Diagn. 2006, 8:157-69.
21. Shibutani M, Uneyama C, Miyazaki K. Methacarn fixation: a novel tool for analysis of gene expressions in paraffin-embedded tissue specimens. Lab Invest. 2000, 80:199-208.
22. Shibutani M, Uneyama C. Methacarn: a fixation tool for multipurpose genetic analysis from paraffin-embedded tissues. Methods Enzymol. 2002, 356:114-25.
23. Gipponi M, Canavese G, Lionetto R. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Eur J Surg Oncol. 2006, 32:143-7.
24. Puchtler H, Waldrop FS, Meloan SN. Methacarn (methanol-Carnoy) fixation. Practical and theoretical considerations. Histochemie. 1970, 21:97-116.
25. Pietribiasi F, De Rosa G, Arisio R. Protocol for diagnostic assessment of sentinel lymph node in breast pathology: a proposal of SIAPEC-IAP, Piemonte Region, Italy. Pathologica. 2006, 98:167-70.
26. Mori M, Mimori K, Inoue H. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995, 55:3417-20.
27. Balducci E, Azzarello G, Valori L. A new nested primer pair improves the specificity of CK-19 mRNA detection by RT-PCR in occult breast cancer cells. Int J Biol Markers. 2005, 20:28-33.
28. Don RH, Cox PT, Wainwright BJ. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 1991, 19:4008.
29. Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol. 2004, 57:467-71.
30. Querzoli P, Pedriali M, Rinaldi R. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res. 2006, 12:6696-701.
31. Kahn HJ, Hanna WM, Chapman JA. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J. 2006, 12:294-301.
32. Valeria D, Daniela A, Fernando P. Sentinel lymph node molecular pathology in breast carcinoma. Diagn Mol Pathol 2008 Mar 28
33. Tsujimoto M, Nakabayashi K, Yoshidome K. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007, 16:4807-16.
34. Visser M, Jiwa M, Horstman A. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008, 122:2562-7.
35. Viale G, Dell'Orto P, Biasi MO. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008, 247:136-42.